Correlation Between Milestone Pharmaceuticals and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Anebulo Pharmaceuticals.
Diversification Opportunities for Milestone Pharmaceuticals and Anebulo Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Anebulo is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.74 times more return on investment than Anebulo Pharmaceuticals. However, Milestone Pharmaceuticals is 1.35 times less risky than Anebulo Pharmaceuticals. It trades about 0.28 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 144.00 in Milestone Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Anebulo Pharmaceuticals |
Milestone Pharmaceuticals and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Anebulo Pharmaceuticals
The main advantage of trading using opposite Milestone Pharmaceuticals and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.The idea behind Milestone Pharmaceuticals and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |